DOI:
10.1055/s-00034924
Nuklearmedizin - NuclearMedicine
LinksClose Window
References
Werner RA, Ilhan H, Lehner S. et al.
Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy.
Mol Imaging Biol 2018;
21: 582-590
We do not assume any responsibility for the contents of the web pages of other providers.